To amend sections 3304.23, 4507.06, 4507.13, 4507.51, and 4507.52 and to enact sections 313.133, 3701.1311, and 3705.081 of the Revised Code regarding sudden unexpected death in epilepsy and to allow a person with epilepsy to enroll in the Disability Database and have an epilepsy designation on the person's driver's license or state ID.
HB758 would create a set of new state requirements and options centered on epilepsy and sudden unexpected death in epilepsy (SUDEP). It directs the state medical examiner/coroner system to investigate whether an autopsy subject with epilepsy or a seizure history died from SUDEP, and if so to record that finding on the death certificate and report it to a relevant registry. The bill also requires the Ohio Department of Health to publish SUDEP information online and develop guidance and education for health care practitioners and the public.
The bill further expands disclosure and identification options for people with epilepsy. It allows a person with epilepsy to voluntarily enroll in the state disability database, and it adds an epilepsy designation symbol to driver’s licenses and state identification cards for those who request it. It also requires the state to make the enrollment form available online and conduct outreach about the database. In addition, the bill mandates that health care practitioners who primarily treat epilepsy patients provide counseling about SUDEP risk and refer patients to state guidance, while granting limited liability protection when those counseling requirements are met.
HB758 would also change insurance and Medicaid coverage rules. Health benefit plans would have to cover people with epilepsy on the same basis as others and could not terminate or refuse renewal solely because of epilepsy. Those plans would also have to cover seizure detection devices when prescribed by an epilepsy specialist and found medically necessary. Medicaid would likewise be required to cover seizure detection devices as durable medical equipment, including related subscriptions or services, when medically necessary and likely to reduce harm or improve diagnosis or treatment.
The bill’s overall impact on state law is broad but targeted: it adds new public-health reporting duties, new patient-education obligations, new identification-card and disability-database procedures, and new coverage mandates for private insurance and Medicaid. It also amends motor vehicle and identification statutes to allow an epilepsy symbol on licenses and ID cards, alongside existing options for veterans and health-care directives. The bill would therefore affect coroners, the Department of Health, the Department of Public Safety, disability agencies, insurers, Medicaid, and people diagnosed with epilepsy.
Because the bill was only introduced and there are no recorded committee transcripts or votes in the provided material, there is no documented legislative debate to gauge support or opposition. Based on the text alone, the measure appears to be framed as a public-health and patient-safety bill, with an emphasis on awareness, early counseling, and access to seizure-detection technology. Potential points of contention would likely involve the new insurance and Medicaid mandates, the liability provisions for clinicians, and the privacy or stigma implications of an epilepsy designation on state-issued identification.
HB758 would amend Ohio law to create new SUDEP reporting and education requirements, authorize voluntary disability-database enrollment for people with epilepsy, and permit an epilepsy symbol on driver’s licenses and state ID cards. It would also impose coverage mandates on health benefit plans and Medicaid for seizure detection devices and prohibit epilepsy-based denial or termination of private health coverage. The bill would affect coroners, health care practitioners, the Department of Health, the Department of Public Safety, disability agencies, insurers, and Medicaid recipients with epilepsy.
No committee testimony or votes are provided, so there is no recorded legislative sentiment to summarize. The bill’s structure suggests a generally supportive, health-oriented approach focused on patient safety, awareness, and access to devices and information. The absence of recorded opposition in the available materials means any controversy is only inferable from the policy choices in the bill itself, not from the legislative record.
The most likely areas of contention are the mandatory insurance and Medicaid coverage requirements for seizure detection devices, which would impose new benefit obligations and payment rules on payers. Another possible issue is the epilepsy designation on driver’s licenses and state ID cards, which may raise privacy, stigma, or voluntary-disclosure concerns even though the bill makes the designation optional. The clinician counseling mandate and related immunity provision could also draw scrutiny over documentation burdens and the standard for proving whether counseling was adequately provided.